Table 7. Lipid parameters expressed in mM in the mildly elevated total cholesterol group (TC <5–5.9mmol mM) between baseline and 12 weeks intervention study in the active (Lactobacillus plantarum ECGC 13110402) and placebo treatment groups.
| Outcome | Group | N | Baseline Mean (SD) |
12 weeks Mean (SD) |
Change Mean (SD) [range] |
% Change Mean (SD) [range] |
Group Difference Mean (95% CI) |
P-value |
|---|---|---|---|---|---|---|---|---|
| TC | Placebo | 9 | 5.48 (0.25) | 5.52 (0.64) | 0.04 (0.74) [-0.8, 1.2] | 1.1 (13.8) [-14.5, 22.2] | 0 | |
| Active | 8 | 5.55 (0.24) | 5.25 (0.54) | -0.30 (0.64) [-1.3, 0.6] | -5.2 (11.4) [-22.4, 11.8] | -0.23 (-0.87, 0.40) | 0.44 | |
| HDL-C | Placebo | 9 | 1.30 (0.26) | 1.31 (0.33) | 0.01 (0.15) [-0.2, 0.2] | 0.3 (11.2) [-12.5, 15.4] | 0 | |
| Active | 8 | 1.50 (0.47) | 1.51 (0.49) | 0.01 (0.1) [-0.1, 0.2] | 0.6 (6.4) [-8.3, 11.8] | -0.01 (-0.15, 0.14) | 0.91 | |
| LDL-C | Placebo | 9 | 3.61 (0.27) | 3.63 (0.54) | 0.02 (0.67) [-0.8, 1.1] | 1.5 (19.2) [-21.1, 33.3] | 0 | |
| Active | 8 | 3.55 (0.40) | 3.16 (0.58) | -0.39 (0.65) [-1.3, 0.6] | -10.2 (18.3) [-36.4, 18.8 | -0.47 (-1.08, 0.13) | 0.11 | |
| TAG | Placebo | 9 | 1.24 (0.42) | 1.29 (0.48) | 0.04 (0.46) [-0.9, 0.6] | 10.7 (39.3) [-52.9, 83.3] | 0 | |
| Active | 8 | 1.11 (0.58) | 1.26 (0.92) | 0.15 (0.38) [-0.3, 0.7] | 5.9 (26.4) [-33.3, 41.2] | 0.13 (-0.33, 0.58) | 0.56 |
TC: total cholesterol; HDL: High-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; TAG: triacylglycerol; N: number of participants